Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1020-2025

HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic Recall

HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic

FDA recall Class II

Ongoing

FDA lists this Class II recall for HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1020-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Dec 18, 2024
FDA report date
Feb 5, 2025
Quantity in commerce
10,952 units (5,303 US, 5,649 OUS) (Additional 11,562 units updated 4/15/2026)
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic

Affected model & UDI checker

Search the exact identifiers published for Z-1020-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedHemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnosticCheck source notice08426950472483
FDA code information

Part Number: 0020300600; UDI-DI: 08426950472483; Lot Numbers: N0128933, N0220450, N0522479, N0724070, N1026509, N0239584, N0531891, N0733658, N0249207, N0442161, N0744673; ****Lot numbers added 4/15/2026**** N0531891, N0733658, N0249207, N0442161, N0744673, N1147734, N020463, N0250464, N0452277, N0553155, N0754506;

View the original FDA recall notice

Why was this product recalled?

Control indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range.

What actions did Instrumentation Laboratory take?

On December 18, 2024 URGENT MEDICAL DEVICE CORRECTION letters were email to customers. Mandatory Customer Actions Based on the above, please take the following immediate actions: - Check inventory for lots of HemosIL Heparin Calibrators (Part No. 0020300600). See Appendix A for a list of in-date lots with corrected value assignments for the HEP CAL 2 and HEP CAL 3 levels. - Follow the instructions below to update the ACL TOP test parameters (same instructions for all models): - Select Setup from the menu bar and then select Test List from the dropdown menu. - From Test List , double click on the Test Code Anti-Xa to open Test Definition Anti-Xa . - From Test Definition Anti-Xa, click on Pre-diluted calibrators under the header Calibration . An editable table titled Calibration points will appear with HEP CAL 1, HEP CAL 2, and HEP CAL 3 and their predefined Target Values IU/mL of 0.00, 0.80 and 2.00, respectively. - In the Calibration points table, change the target values for HEP CAL 2 and HEP CAL 3 to the lot-specific calibrator values provided in Appendix A. - After entering the corrected HEP CAL 2 and HEP CAL 3 values, click on the save icon (picture of floppy disk) to save the changes. - Recalibrate using the HemosIL Liquid Anti-Xa assay lot in use after making the test parameter update. - Run quality controls per labeled instructions for use. If needed, determine control ranges for HemosIL UF Heparin Controls (Part No. 0020300300) and HemosIL Low Molecular Weight Heparin Controls (Part No. 0020300200) in accordance with your internal protocol until the new acceptance ranges are available. - Repeat the above test parameter update, recalibration, and quality control for all ACL TOP instruments. - Share this information with your laboratory staff. - Forward this notification to all affected locations within your facility. - Retain a copy of this notification for your records. - Complete and sign the enclosed Mandatory Response Tracking Form a

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology